{"id":244573,"date":"2026-09-28T09:08:05","date_gmt":"2026-09-28T14:08:05","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/09\/tissue-specific-aging-clocks-map-structured-aging-modulatory-drug-score-patterns-across-49-human-tissue-and-cell-line-categories"},"modified":"2026-09-28T09:08:05","modified_gmt":"2026-09-28T14:08:05","slug":"tissue-specific-aging-clocks-map-structured-aging-modulatory-drug-score-patterns-across-49-human-tissue-and-cell-line-categories","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/09\/tissue-specific-aging-clocks-map-structured-aging-modulatory-drug-score-patterns-across-49-human-tissue-and-cell-line-categories","title":{"rendered":"Tissue-specific aging clocks map structured aging-modulatory drug-score patterns across 49 human tissue and cell-line categories"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/tissue-specific-aging-clocks-map-structured-aging-modulatory-drug-score-patterns-across-49-human-tissue-and-cell-line-categories.jpg\"><\/a><\/p>\n<p>Aging clocks are typically trained on pooled multi-tissue data, implicitly assuming that aging is uniform across organs. Here we challenge this assumption by constructing 49 transcriptomic clocks across 47 tissue types and 2 cell-line categories from GTEx v8 (948 unique donors contributing to the retained clock categories) using donor-grouped cross-validation. Clocks achieved a median Pearson r of 0.543 (best: artery aorta, r = 0.855). We identified 10,253 unique clock genes, of which 69.2% appeared in only one tissue; however, null simulation confirmed that this low overlap is the expected consequence of sparse elastic-net selection rather than biological tissue-specificity. We then projected 3,926 LINCS L1000 compound-name entries onto each clock to build a drug \u00d7 category age-reversal matrix. At a permissive threshold (|score|&gt; 1.0), 94.2% of drugs showed mixed score directions (positive in some categories and negative in others). This permissive mixed-direction proportion was descriptive and did not itself exceed shuffled expectations. Under a more stringent exploratory criterion requiring |score|&gt; 2.0 in at least three categories in each direction, 2.8% of compound entries showed pronounced bidirectional divergence, compared with approximately 0.1% under the shuffled null. Compound rankings remained stable when analysis was restricted to the 34 clocks with r \u2265 0.5 (Spearman \u03c1 = 0.897 versus the full analysis). A Jaccard-based enrichment statistic yielded highly concordant compound rankings (median per-category Spearman \u03c1 = 0.961), indicating that results were not artifacts of the enrichment method. After Benjamini\u2013Hochberg FDR correction across all 192,374 drug-category pairs, only 0.79% reached FDR &lt; 0.05, indicating that individual drug-category calls require caution. Rapamycin showed net pro-aging transcriptional signatures in our system; we explicitly emphasize that transcriptome-based scores and organismal lifespan are distinct endpoints. DepMap CRISPR analysis was repeated after GTEx-based standardization across 13 matched categories, although individual gene-level results were limited. Four statistical robustness tests confirmed model stability. These findings describe category-associated drug-score patterns and provide a tissue-aware resource for generating hypotheses about drug responses, while cautioning against over-interpretation of individual drug-category predictions without experimental validation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aging clocks are typically trained on pooled multi-tissue data, implicitly assuming that aging is uniform across organs. Here we challenge this assumption by constructing 49 transcriptomic clocks across 47 tissue types and 2 cell-line categories from GTEx v8 (948 unique donors contributing to the retained clock categories) using donor-grouped cross-validation. Clocks achieved a median Pearson [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,269],"tags":[],"class_list":["post-244573","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/244573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=244573"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/244573\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=244573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=244573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=244573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}